Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 47 matching records.
47 results — page 1 of 2
- Level DAnimal StudyPubMed
Adipose mesenchymal stem cell-derived nanovesicles as a therapeutic strategy for oral mucosal regeneration after chemotherapy in a rat model.
Animal Study on Chronic Wound, published in J Tissue Eng (2026) — summary generated from the PubMed abstract.
- 2026
J Tissue Eng - Level CProspective StudyPubMed
Grape Pomace Polyphenolic Extract Promotes Osteogenic Differentiation in Human Mesenchymal Stem Cells Through Activation of RUNX2 and NRF2 Transcription Factors: A Potential Natural Strategy for Osteoporosis Prevention.
Prospective Study, published in Biology (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Biology (Basel) - Level DNarrative ReviewEurope PMC
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: a promising strategy for treating retinal degenerative diseases
Narrative Review on Chronic Inflammation, published in Mol Med (2025) — summary generated from the PubMed abstract.
- 2025
Mol Med9 citations - Level DNarrative ReviewPubMed
Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury.
Narrative Review on Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther10 citations - Level DLaboratory StudyEurope PMC
Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model
Laboratory Study on Systemic / IV, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Mol Sci3 citations - Level BClinical TrialEurope PMC
Mesenchymal stem cells as a therapeutic strategy to combat oxidative stress-mediated neuropathic pain
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Bioimpacts (2025) — summary generated from the PubMed abstract.
- 2025
Bioimpacts - Level DLaboratory StudyEurope PMC
TNFRSF11B-modified umbilical cord mesenchymal stem cells as a novel strategy for bone-related diseases by suppressing osteoclast activity
Laboratory Study, published in J Orthop Surg Res (2025) — summary generated from the PubMed abstract.
- 2025
J Orthop Surg Res2 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived exosomes as a potential therapeutic strategy for ferroptosis
Narrative Review on Neuroinflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cells: A new strategy for the treatment of femoral head necrosis
Narrative Review on Face & Skin, Hip, Systemic / IV, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level DNarrative ReviewEurope PMC
From laboratory to clinic: a precise treatment strategy of mesenchymal stem cells-derived exosomes pretreated by simulating disease microenvironment
Narrative Review, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol1 citations - Level DAnimal StudyEurope PMC
Gingival mesenchymal stem cell-derived exosomal miR-23a-3p targets IL-6R to attenuate autoimmune insulitis: a cell-free therapeutic strategy for type 1 diabetes
Animal Study on Type 1 Diabetes, Immune Modulation, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther2 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Spinal Cord Injury
Narrative Review on Spinal Cord Injury, Neuroinflammation, Scar, Chronic Inflammation, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.
- 2025
Int J Nanomedicine2 citations - Level DNarrative ReviewEurope PMC
Strategy for Clinical Setting of Co-transplantation of Mesenchymal Stem Cells and Pancreatic Islets
Narrative Review on Type 1 Diabetes, Immune Modulation, published in Cell Transplant (2024) — summary generated from the PubMed abstract.
- 2024
Cell Transplant13 citations - Level DNarrative ReviewEurope PMC
Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease
Narrative Review on Face & Skin, published in World J Stem Cells (2024) — summary generated from the PubMed abstract.
- 2024
World J Stem Cells11 citations - Level DLaboratory StudyPubMed
Mesenchymal stem cell-derived extracellular vesicles: A promising therapeutic strategy in diabetic osteoporosis.
Laboratory Study on Systemic / IV, published in World J Diabetes (2024) — summary generated from the PubMed abstract.
- 2024
World J Diabetes2 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Narrative Review, published in Cell Commun Signal (2023) — summary generated from the PubMed abstract.
- 2023
Cell Commun Signal52 citations - Level DAnimal StudyPubMed
Carbachol, along with calcium, indicates new strategy in neural differentiation of human adipose tissue-derived mesenchymal stem cells in vitro .
Animal Study, published in Regen Ther (2023) — summary generated from the PubMed abstract.
- 2023
Regen Ther - Level CRetrospective StudyPubMed
Adipose-Derived Stromal Vascular Fractions Are Comparable With Allogenic Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells as a Supplementary Strategy of High Tibial Osteotomy for Varus Knee Osteoarthritis.
Retrospective Study with a reported sample of 25 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Arthrosc Sports Med Rehabil (2023) — summary generated from the PubMed abstract.
- 2023
- n = 25
Arthrosc Sports Med Rehabil10 citations - Level DAnimal StudyEurope PMC
A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement
Animal Study, published in Mol Med Rep (2022) — summary generated from the PubMed abstract.
- 2022
Mol Med Rep4 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stromal Cell Mitochondrial Transfer as a Cell Rescue Strategy in Regenerative Medicine: A Review of Evidence in Preclinical Models
Narrative Review, published in Stem Cells Transl Med (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cells Transl Med51 citations - Level DLaboratory StudyPubMed
Delayed Supplementation Strategy of Extracellular Vesicles from Adipose-Derived Mesenchymal Stromal Cells with Improved Proregenerative Efficiency in a Fat Transplantation Model.
Laboratory Study with a reported sample of 8 on Chronic Wound, published in Stem Cells Int (2022) — summary generated from the PubMed abstract.
- 2022
- n = 8
Stem Cells Int3 citations - Level DLaboratory StudyEurope PMC
Decoding Distinct Ganglioside Patterns of Native and Differentiated Mesenchymal Stem Cells by a Novel Glycolipidomics Profiling Strategy
Laboratory Study on Face & Skin, published in JACS Au (2022) — summary generated from the PubMed abstract.
- 2022
JACS Au13 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review
Narrative Review on Osteoarthritis, published in Biomater Transl (2022) — summary generated from the PubMed abstract.
- 2022
Biomater Transl59 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications
Narrative Review on Type 1 Diabetes, Diabetic Foot, published in Front Endocrinol (Lausanne) (2021) — summary generated from the PubMed abstract.
- 2021
Front Endocrinol (Lausanne)90 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406